APC and colorectal cancer: Lately, reports have stated that in colorectal cancer with classical APC gene mutation, the protein stability of Axin could be enhanced by inhibiting the activity of TNKS1, which further induces β-catenin degradation and Wnt signaling pathway inhibition [9].